Chinook Therapeutics Inc Cvr (ADRO)

R&D Expenses

$51.30M

TTM · Period ending: · USD

ADRO logo

ADRO R&D Expenses

Latest reported$51.30M
ADRO R&D Expenses ($10.69M → $51.30M)
High-resolution chart · PNG

ADRO r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Chinook Therapeutics Inc Cvr R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
67,045,000
75,836,000
89,382,000
87,718,000
58,649,000
23,513,000
10,687,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.